Ibrance on SilverScript Choice (S5601-038)
palbociclib
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 21 per 28 days.
$3,483.09
Patient pays / month, after deductible
$3,944.34
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
IBRANCE 125 mg Capsule at a preferred retail pharmacy, from the plan's negotiated price of $13,932.34 for a month. Other covered strengths are listed below.
Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| IBRANCE 125 mg Capsule | 5 | $3,483.09 | PA · 21 per 28 days |
| IBRANCE 75 mg Tablet, Film Coated | 5 | $4,458.47 | PA · 21 per 28 days |
| IBRANCE 100 mg Tablet, Film Coated | 5 | $4,446.30 | PA · 21 per 28 days |
| IBRANCE 125 mg Tablet, Film Coated | 5 | $4,431.97 | PA · 21 per 28 days |
Other CDK4/6 inhibitors on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-038